Think you know all you need to know, about vaccines? Watch this video!
ABOUT DR. THERESA DEISHER
From this page: https://www.soundchoice.org/about-us/
Dr. Deisher’s career has focused on discovering and developing new therapies for grievous human illness. Dr. Deisher obtained her Ph.D. in Molecular and Cellular Physiology from Stanford University and has spent over 30 years in commercial biotechnology. Prior to founding AVM Biotechnology and Sound Choice Pharmaceutical Institute (SCPI), she worked with leading biotechnology companies, including Genentech, Repligen, ZymoGenetics, Immunex, and Amgen. AVM Biotechnology does not use morally illicit material in any process and develops products that improve outcomes without additional suffering, because side effects from treatments of cancers or infections should never be worse than the diseases themselves. SCPI’s mission is to end human trafficking in biomedical research.
Dr. Deisher is an inventor on 47 issued US/EU/Japan patents and 4 discoveries in clinical trials. She was the first to discover adult cardiac derived stem cells and has been a champion of adult stem cell research. Dr. Deisher was a plaintiff in the US federal lawsuit to prohibit the use of federal tax-payer dollars for embryo-destructive research, which was instrumental in steering science towards adult stem cell research.
She is a frequent lecturer on stem cell issues and the medical and ethical concerns with the use of aborted human fetal DNA in vaccine production. She has appeared on numerous radio and television shows.
COVID-19 VACCINES THAT ARE MANUFACTURED USING ABORTED FETAL DNA

SOURCE:
Vaccines that use human fetal cells draw fire
BY MEREDITH WADMAN
SCIENCE12 JUN 2020 : 1170-1171
According to Robert Kennedy, today's vaccines are unavoidably unsafe. And from the research I've done, it seems that he has good reason for saying this.
We used to get 3 vaccines. Nowadays, kids have to get 72 vaccines, just to stay in school.
We started this discussion by talking about how do you avoid the whole discussion about mandating vaccines? The way that you do that is you have a transparent process where people see that the vaccine is going to be tested, they see that it's tested fairly against a placebo, that there's long-term tests that are going to be evidenced by all of these difficulties and and that it's transparent and open and yet, what we've seen from the current group of covet vaccines is none of that's happening. They're skipping keys key parts of the test.
The Moderna vaccine, which is the lead candidate, skipped the animal testing altogether. When they came to human testing, they tested it on 45 people, they had a high-dose group of 15 people, a medium dose group 15 people, and a low dose growth group of people. In the low dose group one of the people got so sick from the vaccine, they had to be hospitalized. That's six percent. In the high dose group three people got so sick they had to be hospitalized. That's twenty percent. They're going ahead and making two billion doses of that vaccine.
And by the way the people that they test them on alan are not typical Americans. They use what they call exclusionary criteria. They are only giving these vaccines in these tests that they're doing to the healthiest people. If you look at their exclusionary idea you cannot be pregnant you cannot be overweight, you must have never smoked a cigarette, you must have never vaped, you must have no respiratory problems in your family, you can't suffer asthma, you can't have diabetes, you can't have rheumatoid arthritis, or any autoimmune disease, there has to be no history of seizure in your family.
These are the people they're testing the vaccine on but that's not who they're going to give them to. What happens if.. these people are like the Avengers! They're like Superman, you can shoot them with a bullet and they won't go down. What happens when they give them to the typical American? You know, Sally six-pack and Joe bag of Donuts who's 50 pounds overweight and has diabetes? What is going to happen then? You're not going to see 20 percent. You're going to see a lot of people dropping dead. These people lost consciousness. They had to go to hospital, they had huge fevers and they're the healthiest people in the world. So any other medicine, Alan, that had that kind of profile in its original phase, one study would be DOA.
The problem is, Anthony Fauci put 500 million dollars of our dollars into that vaccine. He owns half the patent. He has five guys working for him, who are entitled to collect royalties from that. So you have a corrupt system, and now they've got a vaccine that is too big to fail. And instead of saying hey this was a terrible terrible mistake, they're saying: "We are going to order 2 billion doses of this!"
And you've got to understand, Alan, with these COVID vaccines, these companies are playing with house money. They're not spending anything on it, and they have NO liability. So if they kill 20 people or 200 people, 2 000 people in their clinical trials, big deal they have zero liability! And guess what, if wasted money their money because we're giving them the money to play with. People like me and people in our community are looking at this process and we're saying whatever comes out of that process we don't want to take it because we're seeing how the sausage gets made and it's really sickening. No medical product in the world would be able to go forward with the profile that Moderna has.
Here's what they find. The CDC said the flu vaccine is 35 percent effective, that's what they claim. The Cochrane Collaboration said NO. You have to give 100 flu shots to prevent one case of flu.
In a million years i would not take the flu shot and i'll tell you why. Because this is what Cochrane and BMJ have found.
And in fact, the senior scientist at CDC, today, the Senior vaccine safety scientist, who's still at CDC, he was the senior scientist there for 18 years, he is the author or co-author on all of the major studies that the CDC has produced on vaccine safety, and particularly the studies that shows that vaccine that does not cause autism. His name is Dr. William Thompson. 3 years ago, he came forward and said we have been ordered to fake all the science for the last decade, on Autism. And he said, in fact, we were in the major study which is called Distemino 2004, it's the most latest study on this study subject on Pubmed. He said in that study we found out that black boys who get the MMR vaccine had a 363% greater risk of getting an autism diagnosis than black boys who waited, after 3-6 months. He said he was ordered to come into a conference room with all that data, with his 4 other co-authors, by their CDC boss Frank Destefano, who then ordered them to destroy that data, in front of him, in CDC headquarters, and then publish that study, saying there is no effect.
The vaccine act gave vaccine companies blanket immunity from liability.
Vaccines have another exemption that most people don't know about: They are the only medical product that does not have to be safety tested against a placebo. And that exemption is an artifact of CDC's legacy as the public health service, which was a quasi-military agency which is why people at CDC have military ranks like surgeon general, and they wear uniforms.
The vaccine program was conceived as a national security defense against biological attacks on our country and they wanted to make sure that if the Russians attacked us in the biological age and Anthrax or something like that we could quickly formulate a vaccine and and deploy it to 200 million american civilians without regulatory impediments.
They said if we call it a medicine we're going to have to test it and that takes five years double-blind placebo testing, so let's call it something else. We'll call it a biologic and we'll exempt biologics from safety testing. So not a single one of the vaccines that 72 vaccines now our children have ever been tested against a placebo.
And I in fact sued HHS in 2016 and said show me any placebo studies that you have for any vaccines, and they were unable to do so. None of them have been tested it and you don't have to sue them like I did. Anybody can go on their cell phone and look up manufacturers' inserts. Hepatitis B vaccine, Gardisil vaccine, polio vaccine. You know how many days the current polio vaccine... you know how many days it was safety tested for, Alan? 48 hours.
The hepatitis B vaccine, the Glaxo version was four days. The Merck version was 5 days. That means that if the baby they gave that to had a seizure on day six it never happened, if the baby died on day six, it never happened. If the baby got food allergies that were diagnosed two years later it never happened. If the baby got autism which is not diagnosed till four years of age, 4.2 years of age it never happened. Autoimmune diseases? You cannot see those if you have short-term studies, and you can't see any risk if you don't test against the placebo. And my question is nobody knows because of that nobody knows risk profile or any vaccine that is currently on the schedule and that means nobody can say with any scientific certainty that vaccine is averting more injuries and deaths than it's causing. And my question is how in the heck can we be mandated to children that they take a medical product for which we do not know the risks, and to me that is criminal.
https://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=s9836
Calling the Shots:
Immunization Finance Policies and Practices
Institute of Medicine
Public Meeting
June 16, 2000
Talking Points
by
Bernard Guyer
Professor and Chair, Department of Population and Family Health Sciences
Johns Hopkins School of Hygiene and Public Health
and
Chair, Committee on Immunization Finance Policies and Practices
Good morning. David Smith, the committee vice chair, and I are here today to present the findings and recommendations of a new report from the Institute of Medicine. It raises a public health warning that is too risky to ignore. The nation's immunization system is weakening, showing signs of strain, and history has shown that the price of falling vaccination rates too often is an outbreak of disease.
This report, Calling the Shots: Immunization Finance Policies and Practices, was requested by the U.S. Senate Committee on Appropriations and was sponsored by the Centers for Disease Control and Prevention. The study represents a comprehensive examination of the ways in which federal and state governments finance their public health efforts in the area of immunization. Our committee met five times within an 18-month period, prepared eight case studies, commissioned a 50-state survey, organized a one-day workshop, and conducted four site visits in the course of our fact-finding and deliberations.
As a result of this effort, our committee concluded that vaccines are a powerful technology to prevent disease, but that the nation's health care system is not fully realizing their potential. There have been cycles of interest in immunization in this country, and the committee is concerned that currently interest is flagging. Our immunization system is a national treasure that we cannot take for granted. It was neglect of this issue that led to the measles outbreaks in 1989-90. Constant vigilance is required to protect populations against vaccine-preventable diseases, and the country must do better. The 11,000 infants that are born every day must be routinely vaccinated, and the needs of special at-risk populations must be addressed.
The immunization system is again showing signs of strain and instability. We still have not achieved the national objective of fully immunizing 90 percent of 2-year-olds. There are disparities in coverage between rich and poor, and the result of these disparities shows up in the large pockets of unvaccinated children in large cities. Immunization coverage is even lower among adults and the elderly. Yet, science continues to create new vaccines, and the vaccination schedule is becoming increasingly complex. Further, the health care system is changing dramatically and now depends more heavily on the private sector to administer publicly purchased vaccines for disadvantaged groups. Meanwhile, federal resources for immunizations have decreased over the last five years.
This report was requested because of the Senate Appropriations Committee's concern about the financing of immunization programs through the 1990s. Federal budgets for these programs experienced dramatic shifts during this period, rising very quickly in the early 1990s and then falling equally as fast over the last five years. These budgets provide funds that support immunization programs in each state. Our committee soon realized that although the United States had achieved record highs in rates of immunization coverage, these shifts in funding had eroded the national immunization system and could not continue without causing serious damage to it.
The committee's overall findings and recommendations present a long-term, strategic approach quite different from the current and uncertain annual budget battles. We concluded that unpredictable funding has created instability and uncertainty in state and local planning efforts. Also, because disease does not recognize geographic boundaries, our report underscores the need for an immunization policy that is national in scope, yet flexible enough to adapt to state and local needs and resources. Implementing this policy, however, takes much more than vaccines, needles, and medical staff. Federal and state governments need to do much more to strengthen the ability of public health officials to monitor the system and shift resources to areas of need. Still, the reality is that vaccinations primarily take place in private settings -- in a doctor's office or a private clinic. Therefore, private health plans can and should do more to implement immunization surveillance and prevention programs, but require assistance, oversight, and incentives from the states to perform this role.
Our committee has recommended a plan including the following strategic elements:
> A long-term finance plan that can provide about $1.5 billion over a five-year period as a stable investment in the immunization infrastructure, totaling $300 million annually from state and federal governments. About $875 million of this total represents new funding.
> A better basis for the federal-state partnership that supports immunization efforts, including a shift to system for allocating federal grants based on a formula that will distribute the money more effectively, as well as a required state contribution to strengthen local involvement.
> Clarification of the system's function as a platform for specific programs.
> A greater public health role for the private sector.
> New measurement tools that improve the surveillance of immunization rates in selected communities, and add a population focus to performance assessment tools.
> A broadened perspective on immunization that would include adults, adolescents, elderly, as well as infants.
To implement these elements of our strategic plan, the committee recommends that federal and state governments and other players in the immunization system undertake a number of steps, including:
1. Congress and state legislatures should sustain current budgets for purchasing children's vaccines, but develop a mechanism that can provide funding for new vaccines, such as the new pneumococcal conjugate for infants.
2. Congress and state legislatures should provide an additional $50 million in federal funds and an additional $11 million in state funds to purchase vaccines for uninsured adults, especially adults who are under age 65 and have chronic health conditions such as diabetes, heart and lung disease, or HIV infections, and who are especially vulnerable to infectious disease.
3. Congress and state legislatures should increase funding for state immunization infrastructure support to $300 million each year. This figure includes an increase of $75 million over current federal awards (for a total of $200 million each year for infrastructure support) and an annual increase of $100 million over current state spending efforts.
4. The federal government should replace discretionary grants with formula-grant legislation that reflects states' need, capacity and performance; introduces a state matching requirement; and provides a small amount of funding for CDC to set aside for outbreaks.
5. Federal agencies, states, and Congress should initiate a dialogue to develop consensus around new legislation that could be introduced during the reauthorization process that begins next year.
6. The immunization system should develop a set of consistent and comparable immunization measures that can monitor immunization status of children and adults in private and public plans; harmonize national immunization survey methods with those used by many managed care plans; achieve fairness in public and private health plan coverage of vaccine services, and clarify the public health role of the private health care delivery systems.
Dr. Smith and I would now be glad to take your questions. We're recording this meeting, so please step to the microphone in the aisle and identify yourself and your organization when you speak.
Web results
He had a severe reaction to Moderna Covid-19 vaccine. He's ...
https://www.menshealth.com/health/a19544378/flu-shot-side-effects/
- only about 40–60% of flu shots are effective in preventing the flu each year.
- they can take up to 2 weeks to start working.
- sometimes, they cause mild side effects, such as pain, redness, and swelling at the injection site.
- Soreness, redness, and/or swelling from the shot.
- Headache.
- Fever.
- Nausea.
- Muscle aches.
Thankfully, symptoms don't last long. "Usually these don’t last for more than a day or two,” Pekosz said.
In rare cases, some may experience an allergic reaction to the vaccine. Symptoms include trouble breathing, hives, swelling around the eye or mouth area, weakness or dizziness. Typically, these symptoms occur within a few minutes to hours after the vaccine was given.
If you’re really feeling sick for a sustained amount of time afterwards, well, you probably just caught another virus that the flu vaccine doesn’t protect you against.
"The flu vaccine protects against influenza virus, but there are a number of other viruses that can cause a flu-like disease,” Pekosz said. "Viruses like human parainfluenza virus, respiratory syncytial virus (RSV) and coronaviruses all circulate in fall and early winter, the time that flu vaccination programs are in full-swing." These viruses and their symptoms usually last two to eight days.
Dr Carrie Madej, DO is a Internal Medicine Specialist in McDonough, GA and has over 19 years of experience in the medical field. She graduated from Kansas City Univ Of Medicine Bioscience College Of Osteopathic Medicine medical school in 2001.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.